Flemish population-based cancer screening programs: impact of COVID-19 related shutdown on short-term key performance indicators

[1]  S. Peacock,et al.  Cervical screening during the COVID-19 pandemic: optimising recovery strategies , 2021, The Lancet Public Health.

[2]  E. Heijnsdijk,et al.  Effects of cancer screening restart strategies after COVID-19 disruption , 2021, British Journal of Cancer.

[3]  M. Poljak,et al.  Impact of the COVID-19 pandemic on human papillomavirus-based testing services to support cervical cancer screening. , 2021, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.

[4]  A. Gambini,et al.  Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era , 2021, ESMO Open.

[5]  P. Sasieni,et al.  Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses , 2021, British Journal of Cancer.

[6]  I. Lansdorp-Vogelaar,et al.  Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study , 2021, The Lancet Gastroenterology & Hepatology.

[7]  F. Bazzoli,et al.  Impact of SARS-CoV-2 Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased Mortality , 2020, Clinical Gastroenterology and Hepatology.

[8]  M. V. Van Bockstal,et al.  The Impact of the COVID-19 Pandemic and the Associated Belgian Governmental Measures on Cancer Screening, Surgical Pathology and Cytopathology , 2020, Pathobiology.

[9]  G. Ferrara,et al.  Cancer diagnostic rates during the 2020 ‘lockdown’, due to COVID-19 pandemic, compared with the 2018–2019: an audit study from cellular pathology , 2020, Journal of Clinical Pathology.

[10]  S. Achenbach,et al.  Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology , 2020, European heart journal. Quality of care & clinical outcomes.

[11]  C. Hassan,et al.  COVID-19 and endoscopy: implications for healthcare and digestive cancer screening. , 2020, Nature reviews. Gastroenterology & hepatology.

[12]  I. Nagtegaal,et al.  Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands , 2020, The Lancet Oncology.

[13]  S. Hoeck,et al.  Do socioeconomic factors play a role in nonadherence to follow-up colonoscopy after a positive faecal immunochemical test in the Flemish colorectal cancer screening programme? , 2019, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[14]  E. van Limbergen,et al.  Flemish breast cancer screening programme: 15 years of key performance indicators (2002–2016) , 2019, BMC Cancer.

[15]  Christopher D. Jensen,et al.  Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis , 2017, JAMA.